Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial
Autor: | Premawardhena, Anuja, Wanasinghe, Sakuni, Perera, Chamodi, Wijethilaka, Muditha Nayana, Rajakaruna, R.H.M.G., Samarasinghe, R.A.N.K.K., Williams, Senani, Mettananda, Sachith |
---|---|
Zdroj: | In The Lancet Regional Health - Southeast Asia November 2024 30 |
Databáze: | ScienceDirect |
Externí odkaz: |